Fresenius Medical Care AG & Co. KGaA

NYSE:FMS

Medical - Care Facilities

Healthcare
$20.95 -0.76%

-$0.18 today

Market cap
$11.26B
Beta
0.81
P/E (TTM)
11.9
EPS (TTM)
$3.43
Dividend yield
3.65%
52W Low $20.02High $28.87

Volume 1.92M

Average 0.72M

FMS Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Fresenius Medical Care AG & Co. KGaANYSE: FMS

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin widens to 27.0%

Gross margin was 27.0% in Q2 FY2026, up 1.6 pp from a year earlier. On a trailing-twelve-month basis it was 26.4%, up 1.7 pp year over year. Over 3 fiscal years it widened by 0.4 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
27.0%+1.4 pp QoQ
Last fiscal yearDec 2025
25.6%+1.0 pp YoY
LTMJun 2026
26.4%+1.7 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1.6 pp——
1 year+1.0 pp——
3 years+0.4 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
25.6%
Year-over-year change
+1.0pp

Gross Margin vs competitors

How FMS compares with its peers on the latest reported figures

  • FMS's LTM Jun 2026 gross margin of 26.4% is the lowest of the 4 companies compared; the peer median is 60.7%.
  • Its year-over-year change of +1.7 pp is the 2nd highest of 4, against a peer median of -1.5 pp.
  • Over three fiscal years its change of +0.4 pp compares with a peer median of -2.3 pp.
FMS Competitors Peer median
Gross Margin for FMS and competitors
Company Period LTM level YoY 3-year change
AKBAAkebia Therapeutics, Inc.LTM Mar 202680.9% +8.2 pp-9.0 pp
TVTXTravere Therapeutics, Inc.LTM Sep 202660.7% -37.0 pp+1.9 pp
DVADaVita Inc.LTM Jun 202631.0% -1.5 pp-2.3 pp
FMSFresenius Medical Care AG & Co. KGaALTM Jun 202626.4% +1.7 pp+0.4 pp
Peer median (excluding FMS) 60.7%-1.5 pp-2.3 pp

Competitors are the stored peer set for FMS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue17.62B19.4B19.45B19.34B19.63B
Cost of Revenue12.85B14.5B14.53B14.58B14.6B
Gross Profit4.77B4.89B4.93B4.76B5.03B
Gross Margin27.1%25.2%25.3%24.6%25.6%
Research & Development220.78M228.62M231.97M183.49M157.98M
Selling, General & Admin2.77B3.17B3.2B3.14B3.03B
Operating Expenses2.92B3.38B3.56B3.29B3.2B
Depreciation & Amortization1.62B1.84B1.75B1.74B1.5B
EBITDA3.55B3.42B3.21B3.21B3.4B
EBITDA Margin20.1%17.6%16.5%16.6%17.3%
Operating Income1.85B1.51B1.37B1.47B1.83B
Operating Margin10.5%7.8%7.0%7.6%9.3%
Interest Income73.17M67.66M88.22M71.58M69.61M
Interest Expense353.6M360.14M424.64M407.04M384.41M
Other Income / Expenses(280.43M)(292.48M)(336.42M)(410.45M)(314.59M)
Income Before Tax1.57B1.22B1.03B1.06B1.51B
Pre-Tax Margin8.9%6.3%5.3%5.5%7.7%
Income Tax Expense352.83M324.95M300.56M316.06M320.97M
Net Income969.31M673.41M499M537.91M978.37M
Net Margin5.5%3.5%2.6%2.8%5.0%
EPS (Basic)0.830.570.850.921.68
EPS (Diluted)0.830.570.850.921.68
Weighted Avg Shares1.17B1.17B586.83M586.83M582.38M
Weighted Avg Shares (Diluted)1.17B1.17B586.83M586.83M582.38M

Fresenius Medical Care AG & Co. KGaA

NYSE:FMS

Intrinsic Alpha fair value

Locked

Current Price

$20.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.